These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 10547218

  • 1. Diuretics in cardiovascular therapy: the new clinicopharmacological bases that matter.
    Reyes AJ, Taylor SH.
    Cardiovasc Drugs Ther; 1999 Sep; 13(5):371-98. PubMed ID: 10547218
    [Abstract] [Full Text] [Related]

  • 2. Renal excretory responses to single and repeated administration of diuretics in healthy subjects: clinical connotations.
    Reyes AJ, Leary WP.
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():29-44. PubMed ID: 8435375
    [Abstract] [Full Text] [Related]

  • 3. Clinicopharmacological reappraisal of the potency of diuretics.
    Reyes AJ, Leary WP.
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():23-8. PubMed ID: 8435374
    [Abstract] [Full Text] [Related]

  • 4. Renal excretory profiles of loop diuretics: consequences for therapeutic application.
    Reyes AJ.
    J Cardiovasc Pharmacol; 1993 Jan; 22 Suppl 3():S11-23. PubMed ID: 7506333
    [Abstract] [Full Text] [Related]

  • 5. Effects of diuretics on renal excretory function.
    Reyes AJ.
    Eur Heart J; 1992 Dec; 13 Suppl G():15-21. PubMed ID: 1486900
    [Abstract] [Full Text] [Related]

  • 6. Effects of diuretics on outputs and flows of urine and urinary solutes in healthy subjects.
    Reyes AJ.
    Drugs; 1991 Dec; 41 Suppl 3():35-59. PubMed ID: 1712714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG, Merz E, Brooks DP.
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [Abstract] [Full Text] [Related]

  • 9. Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.
    van Ganse E, Douchamps J, Deger F, Staroukine M, Verniory A, Herchuelz A.
    Eur J Clin Pharmacol; 1986 Aug; 31 Suppl():43-7. PubMed ID: 3536531
    [Abstract] [Full Text] [Related]

  • 10. Saluretic effect of the loop diuretic torasemide in chronic renal failure. Interdependence of electrolyte excretion.
    Knauf H, Mutschler E.
    Eur J Clin Pharmacol; 1990 Aug; 39(4):337-43. PubMed ID: 2076714
    [Abstract] [Full Text] [Related]

  • 11. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT, Charles CJ, Nicholls MG, Richards AM.
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure.
    Kissling KT, Pickworth KK.
    Pharmacotherapy; 2014 Aug; 34(8):882-7. PubMed ID: 24990816
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Torasemide. An update of its pharmacological properties and therapeutic efficacy.
    Dunn CJ, Fitton A, Brogden RN.
    Drugs; 1995 Jan; 49(1):121-42. PubMed ID: 7705212
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA, Buckley MM.
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [Abstract] [Full Text] [Related]

  • 19. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC, Morales-Rull JL, Casado J, Freitas Ramírez A, Manzano L, Formiga F, CLOROTIC investigators.
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.